Quantitative analysis for Inventiva S.A. (IVA) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Sell (26.0) (grade F). 29 signals analyzed (25 differentiated alt-data).
IVA stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $5.16 | $5.00 | $5.01 |
| 2026-05-08 | $5.52 | $5.27 | $5.37 |
| 2026-05-20 | $5.19 | $4.91 | $5.14 |
| 2026-06-02 | $4.67 | $3.81 | $4.09 |
| 2026-06-12 | $3.97 | $3.80 | $3.85 |
| 2026-06-25 | $3.53 | $3.41 | $3.50 |
| 2026-07-08 | $4.74 | $4.20 | $4.39 |
| 2026-07-20 | $4.71 | $4.39 | $4.41 |
| 2026-07-30 | $4.66 | $4.48 | $4.62 |
| 2026-08-12 | $4.82 | $4.67 | $4.68 |
| 2026-08-24 | $4.71 | $4.53 | $4.70 |
| 2026-09-03 | $5.10 | $4.72 | $4.84 |
How Inventiva S.A. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ZURA | Zura Bio Limited | $266M | 38.0 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $264M | 65.0 |
| CCCC | C4 Therapeutics, Inc. | $272M | — |
| PRE | Prenetics Global Limited | $261M | — |
View all Health Care stocks by valuation and signals →
Inventiva S.A. (IVA) scores Strong Sell (26.0), and the composite conceals a 64-point disagreement between its dimensions. It is strongest on analyst consensus at 74, and weakest on technicals at 10. A stock can carry analyst consensus that high while technicals sits at 10; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 74 |
| technicals | 10 |
StoQuant analyzes 29 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Inventiva S.A. (IVA): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/IVA"><img src="https://stoquant.com/badge/IVA.svg" alt="Inventiva S.A. (IVA) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.